BioNTech SE (BNTX) Receivables (2018 - 2026)
BioNTech SE's Receivables was $755.64 million in Q3 2026, down 7.3% from $814.98 million a year earlier but up 303.6% from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) Receivables (2018 - 2026) Analysis & Trends
At the end of FY2025, Receivables at BioNTech SE came in at $1.09 billion, down 29.1% from FY2024.
- Receivables has now declined for four consecutive years, though with a five-year compound annual growth rate of 39.8% (FY2020 to FY2025).
- In earlier years, Receivables was $1.53 billion in FY2024 (-35.7%), $2.39 billion in FY2023 (-68.7%), $7.62 billion in FY2022 (-45.7%) and $14.02 billion in FY2021.
- Quarterly Receivables has moved between $85.35 million (Q2 2024) and $14.17 billion (Q1 2022) over five years.
- Compared with a year earlier, Receivables has declined for five straight quarters, with an average decline of 38.4% over the last seven quarters.
- The best year-over-year quarter for Receivables over five years was Q1 2022 (growth of 404.7%); the worst was Q2 2024 (a decline of 97.1%).
- Per Business Quant data, BNTX's Receivables in the three quarters before Q3 2026 was $187.21 million (Q2 2026), $617.92 million (Q1 2026) and $1.09 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | BioNTech SE | 21.19 Bn | -49.68 Bn | - | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 755.64 Mn |
| Jun 30, 2026 | 187.21 Mn |
| Mar 31, 2026 | 617.92 Mn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 814.98 Mn |
| Jun 30, 2025 | 1.61 Bn |
| Mar 31, 2025 | 1.04 Bn |
| Dec 31, 2024 | 1.53 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 85.35 Mn |
| Mar 31, 2024 | 1.78 Bn |
| Dec 31, 2023 | 2.39 Bn |
| Sep 30, 2023 | 2.12 Bn |
| Jun 30, 2023 | 2.90 Bn |
| Mar 31, 2023 | 7.04 Bn |
| Dec 31, 2022 | 7.62 Bn |
| Sep 30, 2022 | 7.18 Bn |
| Jun 30, 2022 | 10.85 Bn |
| Mar 31, 2022 | 14.17 Bn |
| Dec 31, 2021 | 14.02 Bn |
API Access
BioNTech SE Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();